PRESS: Fierce Biotech - Forge Biologics

Six months after departing Abeona, Tim Miller, Ph.D., is on his next chapter: Forge Biologics, a gene therapy biotech that’s []Read More from PRESS: Fierce Biotech

CDMO Ajinomoto forges ahead with Forge Biologics in $620M acquisition

Endpoints News — J&J ends adult RSV vaccine development; The Broad's Feng Zhang outlines bacterial delivery in new paper

GentiBio - Recent News & Activity

Forge Biologics Launches with $40 Million Series A Financing to Manufacture and Develop Gene Therapies

Forge Biologics Announces Closing of $120 Million Series B Financing

Forge Biologics

Pharma PR & Communications Summit

Forge Bio's Combo Model for Gene Therapies Attracts $40M in Funding - Forge Biologics

Forge Biologics

Columbus Inno - Gene therapy startup Forge Biologics raises $90M on biotech manufacturing strength

Forge Biologics Manufacturing Gene Therapies for Life

Pharma PR & Communications Summit